scholarly journals Epiretinal membrane peeling as the treatment for macular edema associated with isolated retinal astrocytic hamartoma

2021 ◽  
Vol 33 (4) ◽  
pp. 496
Author(s):  
Carlos Cuadros Sanchez ◽  
Beatriz de Luis Eguileor ◽  
Cristina Sacristán Egüén ◽  
Ana Arce Soto ◽  
Nerea Martínez Alday
Keyword(s):  
Macular Edema ◽  
Epiretinal Membrane ◽  
Membrane Peeling ◽  
Astrocytic Hamartoma

Foveal displacement In Eyes With Epiretinal Membrane After Vitrectomy And Membrane Peeling Dystopia fovea and epiretinal membrane

Retina ◽  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Hsiao-Fan Tung ◽  
Yi-Ling Chen ◽  
Hsiao-Yu Tung ◽  
Hsiao-Wei Tung ◽  
San-Ni Chen
Keyword(s):  
Epiretinal Membrane ◽  
Membrane Peeling

Efficacy of Subthreshold Photocoagulation for Persistent Diabetic Macular Edema After Internal Limiting Membrane Peeling: A Retrospective Comparative Study

2021 ◽  
Author(s):  
Hirotsugu Takashina ◽  
Akira Watanabe ◽  
Koji Komatsu ◽  
Tadashi Nakano
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Internal Limiting Membrane ◽  
Macular Thickness ◽  
Internal Limiting Membrane Peeling ◽  
Membrane Peeling ◽  
Group A ◽  
Group B ◽  
Subthreshold Photocoagulation ◽  
Persistent Diabetic Macular Edema

Abstract Background Subthreshold photocoagulation is one of the therapeutic options for treating diabetic macular edema, and have characteristic advantages, which are the lack of chorioretinal damage and the repeatability of the treatment. However, the effect of subthreshold photocoagulation is thought to be minimal among these options. In this study, we retrospectively examined the efficacy of repeated subthreshold photocoagulation for persistent diabetic macular edema after vitrectomy with peeling of the internal limiting membrane. Methods We enrolled ten consecutive eyes of eight patients who underwent monthly Endpoint Management™ (EpM) six times for diabetic macular edema that persisted for more than 3 months after vitrectomy with internal limiting membrane peeling for epiretinal membrane, and classified according to the interval between vitrectomy and initial EpM (Group A: within 6 months, Group B: beyond 6 months). Two type of retinal thickness (central macular thickness and macular thickness within 3mm diameter of the fovea) were measured monthly using optical coherence tomography. Results Mean intervals between vitrectomy and initial EpM were 4.0 ± 1.2 months (range 3–6 months) in Group A (six eyes of five patients) and 17.3 ± 7.5 months (range 10–27 months) in Group B (four eyes of four patients). No other treatments were performed between vitrectomy and initial EpM in Group A, while triamcinolone acetonide injection in the sub-Tenon’s capsule was performed in two eyes in Group B (one eye was injected thrice, the other eye received a single injection). Improvement rates of mean central macular thickness after 6 months were 18.2% in all eyes, 10.8% in Group A, and 28.7% in Group B, and improvement rates of mean macular thickness within 3mm diameter of the fovea after 6 months were 8.5% in all eyes, 4.1% in Group A, and 15.3% in Group B. Conclusions Monthly EpM treatment was efficacious against persistent diabetic macular edema after internal limiting membrane peeling. In particular, the efficacy was greater in eyes in which the initial EpM was performed more than 6 months after vitrectomy. Furthermore, residual efficacy of triamcinolone acetonide, which was injected at the end of vitrectomy, might have contributed to the results.

VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR TRACTIONAL AND NONTRACTIONAL DIABETIC MACULAR EDEMA

Retina ◽  
2015 ◽  
Vol 35 (5) ◽  
pp. 921-928 ◽  
Author(s):  
Sophie Bonnin ◽  
Otman Sandali ◽  
Sébastien Bonnel ◽  
Claire Monin ◽  
Mohamed El Sanharawi
Keyword(s):  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Internal Limiting Membrane ◽  
Internal Limiting Membrane Peeling ◽  
Membrane Peeling
Sign in / Sign up

Export Citation Format

Share Document